Drugs / Interferon ß-1b
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00270816 | Nov 2005 → Aug 2010 | multiple sclerosis | S. Andrea Hospital | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Interferon ß-1b | “Drug: Interferon ß-1b” NCT00270816 ↗ |
| Known as | IFN-b | “To compare a schedule with cyclic withdrawal (CW) of interferon beta (IFN-b) 1b, respect to the full regimen (FR), in relapsing-remitting MS (RR-MS).” PMID 31379701 ↗ Jul 2019 |
| Route | Subcutaneous | “administered subcutaneously (sc)” NCT00270816 ↗ |